COL3A1 Overexpression Associates with Poor Prognosis and Cisplatin Resistance in Lung Cancer.

Background: Collagen type III alpha 1 chain (COL3A1) is reported to mediate drug resistance in various cancers, and public database analysis indicated its overexpression in lung cancer.

Aims: To investigate the effects of COL3A1 on modulating cisplatin (DDP) resistance in lung carcinoma.

Study Design: A cell study.